Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis
2011

Neurotrophin-3 Reduces Neuronal Loss in Pneumococcal Meningitis

Sample size: 47 publication 10 minutes Evidence: moderate

Author Information

Author(s): Demel Cornelia, Hoegen Tobias, Giese Armin, Angele Barbara, Pfister Hans-Walter, Koedel Uwe, Klein Matthias

Primary Institution: Ludwig Maximilians University Munich

Hypothesis

Does systemically applied neurotrophin-3 (NT-3) improve hearing outcomes and neuron survival in pneumococcal meningitis?

Conclusion

Systemically applied NT-3 may help improve hearing outcomes and reduce neuronal loss after pneumococcal meningitis.

Supporting Evidence

  • NT-3 treatment led to a significant decrease in spiral ganglion neuronal loss.
  • Hearing thresholds improved in mice treated with NT-3 compared to placebo.
  • The effects of NT-3 were comparable to those of dexamethasone.
  • Systemically applied NT-3 reached the cochlea, indicating effective delivery.

Takeaway

This study found that a special protein called NT-3 can help protect hearing and brain cells in mice that got a serious infection.

Methodology

Mice were treated with NT-3 or dexamethasone after being infected with pneumococcal bacteria, and their hearing and neuron survival were assessed.

Potential Biases

Potential bias in the assessment of outcomes due to the nature of animal studies.

Limitations

The study was conducted in mice, and the effects in humans may differ; also, the long-term effects of NT-3 therapy are not fully understood.

Participant Demographics

C57BL/6 mice, aged 4-6 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-8-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication